Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Cancer Lett. 2019 Nov 22;470:170–180. doi: 10.1016/j.canlet.2019.11.025

Fig. 5 – IFNAR1 antibody inhibits 4HC-stimulated ISG induction in glioma cultures.

Fig. 5 –

Gene expression data are shown for GL261 (A) and CT-2A (B) cells treated for 4 h with 4HC (20 μM) alone or in combination with IFNAR1 antibody (10 μg/ml), and then incubated for a further 44 h without 4HC, and with or without IFNAR1 antibody (arrows along x-axis), as indicated. Data shown are mean fold-change values ± SD for n= 3 replicate cultures, with intra-sample normalization to the levels of 18S RNA. NS, not significant, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 (one-way ANOVA analysis) for the indicated comparisons.